Dendritic cell therapy is an advanced immunotherapy that utilizes dendritic cells, the immune system’s antigen-presenting cells, to stimulate a targeted immune response against colon cancer.
Details →
The HER2 protein drives tumor growth, making it a key target for targeted therapies for HER2 positive gastric cancer
Details →
Stage 4 stomach cancer, or metastatic gastric cancer, occurs when cancer cells spread beyond the stomach to distant organs such as the liver, lungs, or peritoneum, making treatment more complex
Details →
Colon cancer, a malignancy of the large intestine, is staged using the TNM system (Tumor, Node, Metastasis) to describe tumor size, lymph node involvement, and metastasis.
Details →
The latest stage 4 colon cancer treatment options in 2025 integrate advanced surgical techniques, systemic therapies, and experimental approaches, tailored to tumor biology and patient health.
Details →
Stage 4 rectal cancer is an advanced malignancy where cancer spreads from the rectum to distant organs such as the liver, lungs, bones, or peritoneum.
Details →
Stage 4 gastric cancer is an advanced malignancy where cancer has spread from the stomach to distant organs such as the liver, lungs, lymph nodes, or peritoneum.
Details →
Offering a spectrum of therapies, including minimally invasive stomach cancer surgery, chemotherapy, and innovative approaches like dendritic cell therapy, these centers provide hope for patients at all stages.
Details →
Cervical cancer develops in the cells of the cervix, the lower part of the uterus connecting to the vagina, often linked to persistent human papillomavirus (HPV) infection.
Details →
This blog explores which treatments are available for endometrial cancer, highlighting the role of can we use dendritic cell therapy? in achieving optimal outcomes.
Details →
Dendritic cell therapy is a personalized immunotherapy that uses a patient’s own dendritic cells key immune system components to stimulate a targeted immune response against cancer cells.
Details →
Colorectal cancer (CRC) is a leading global malignancy, with up to 25% of patients developing metastatic colorectal cancer liver, known as CRLM.
Details →
Ovarian cancer, originating in the ovaries, and cervical cancer, often linked to Human Papillomavirus (HPV) infection in the cervix, are significant health challenges for women worldwide
Details →
German cancer clinics excel in providing comprehensive evaluations, combining advanced diagnostics with expertise from specialists in oncology and immunotherapy.
Details →
Liver metastases occur when cancer from other parts of the body, such as the colon, breast, or lung, spreads to the liver, often complicating treatment.
Details →
Germany stands as a global leader in prostate cancer treatment, offering cutting-edge solutions like Lutetium-177 PSMA therapy to transform outcomes for patients with advanced metastatic prostate cancer.
Details →
Germany is a global leader in colon and colorectal cancer treatment, offering innovative solutions like dendritic cell therapy to improve outcomes for patients with colon and colorectal cancer (CRC).
Details →
Liver cancer, particularly HCC, often develops in patients with chronic liver conditions like hepatitis B or C, cirrhosis, or alcohol-related liver disease.
Details →
Dendritic cell therapy leverages the power of dendritic cells, specialized immune cells that identify and present cancer cells to the immune system for targeted destruction.
Details →
